Teva Pharmaceuticals has agreed to pay $425 million to resolve allegations that the company ... submission of false claims to Medicare. 2. The settlement was reached after the government's review ...
The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
The results excluded more than $1.2 billion of one-time costs including a legal settlement and a goodwill impairment for its API business, for which Teva said it would complete a divestment in the ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
Last year, Teva was ordered to pay $225 million to settle price fixing charges in the U.S. related to sales of a cholesterol-lowering drug. The U.S. Justice Department said the agreement also required ...
The settlement resolves allegations that the company engaged in widespread ... The second complaint was filed in 2019 against Teva Pharmaceuticals and 19 of the nation’s largest generic drug ...
As part of the settlement, there was no admission ... the department said. Separately, Teva agreed to resolve allegations that it conspired with other generic drug manufacturers to fix prices ...